SCYNEXIS to Present Positive Interim Data from Ongoing FURI and CARES Studies at the 32nd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Being Held April 23-26 in Lisbon, Portugal

3 years ago

Data from studies evaluating ibrexafungerp in serious fungal infections will be presentedJERSEY CITY, N.J., April 20, 2022 (GLOBE NEWSWIRE) --…

Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board

3 years ago

Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board Vice Admiral (r) Timothy SzymanskiIrvine, CA,…

ICU Medical, Inc. Announces Time of First Quarter 2022 Earnings Conference Call

3 years ago

SAN CLEMENTE, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…

Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022

3 years ago

CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study

3 years ago

New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a…

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

3 years ago

PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that…

Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022

3 years ago

Presentation to review historic issues related to glaucoma therapies and how these may be addressed through the use of Optejet®…

Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta

3 years ago

Global study will evaluate UX143 in pediatric and young adult patients ages 5 to NOVATO, Calif., April 20, 2022 (GLOBE…

Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

3 years ago

HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive informationPLEASANTON, Calif., April 20,…

MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4

3 years ago

MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental…